4Ever Young franchise: what share of units hits the average?
Independence note: this site is not affiliated with 4Ever Young. The name is used only to identify the company discussed (see the publisher disclosure in the footer). Figures below are dated; 4Ever Young’s current official documents control.
Franchise fee
$60,000
All-in investment (Item 7)
~$521,650–$754,900
Ongoing take (Item 6)
7% royalty (monthly minimums) + 2% brand fund + $7,500/mo required local marketing
Footprint
56+ franchised + 3 corporate units (end 2024); PE-backed
Candidate screen
~$400K liquid / $1M net worth
Real momentum
4Ever Young has genuine acceleration: from 6 franchised units in 2022 to 56+ by the end of 2024, private-equity backing (Highmount/Madison), a published Item 19, and an expansion drumbeat through 2026. Its service menu — GLP-1 weight loss, peptides, hormones — sits squarely in the metabolic-longevity lane.
The distribution behind the average
The published $1.11M average unit volume is the headline. Analyses of the same disclosure indicate only about 31% of reporting units meet that average. Averages in young, fast-growing systems are pulled by early flagship units; the median and the distribution are the numbers that describe the unit you would actually own.
The carry cost
7% of gross (with monthly minimums) plus a 2% brand fund plus a required $7,500 monthly local-marketing spend — roughly $90,000 per year of mandated marketing alone — on a buy-in that lands between roughly $522K and $755K. The brand is rented, the territory is exclusive but conditional, and the prescription model requires per-state medical directors.
The screen
The stated candidate screen (~$400K liquid, $1M net worth) prices this system above much of the owner-operator market researching this category. If you clear it comfortably, compare agreements line by line; if you do not, this is not your comparison set.
Take these questions to them
“What percentage of units meets the advertised average — and what does the median unit earn?”
“What do royalty + brand fund + mandated marketing total per year at my projected gross?”
“What are my obligations if the medical director resigns mid-agreement?”
“What do I own at exit, other than the right to sell back into your system?”
Where we stand — disclosedThis site is published by Atlas Metabolic, which offers a 0%-royalty license model in this category (partner owns their own brand; final agreements control). We think the honest comparison — documents, fees, ownership at exit — favors that structure, and you should verify that skepticism-first: see how Atlas structures it, and hold us to the same diligence standard this site applies to everyone else. If you want to see ongoing-fee structures side by side at your own numbers, use the RoyaltyMath calculator.
Sources & dates (retrieved July 29, 2026 unless noted)